Login

Financial Snapshot

Revenue
TTM
$2.811B
Gross Margin
TTM
53.69%
Net Income
TTM
-$1.009B
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
255.43%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$3.084B
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$232.6M

Stock Price

Loading...
Market Cap: $5.5444 Billion

About Teleflex Inc

Teleflex Inc (NYSE: TFX) is a medical device company that designs, manufactures, and sells single-use and reusable medical products used across a range of clinical procedures. Revenue comes from transactional sales of disposable and durable devices to hospitals, clinicians, and other healthcare providers. The 10-K filed 2026-02-27 (accession 000009694326000019) covers the fiscal year ended December 31, 2025, but the filing excerpts provided do not contain sufficient segment revenue breakdowns, product line details, geographic mix, competitive positioning, or leadership information to support additional specific claims. Based solely on the available excerpt, Teleflex is incorporated in a U.S. state, files with the SEC under the Securities Exchange Act, and is listed on a national exchange under ticker TFX. All further operational and financial detail requires access to the full body of the 10-K filing beyond the cover-page excerpt provided.

Source: SEC 10-K, filed 2026-02-27

Industry: Surgical & Medical Instruments & Apparatus Peers: Abbott Laboratories ABIOMED INC Globus Medical Inc HOLOGIC INC IDEXX Laboratories Inc Insulet Corp Masimo Corp Penumbra Inc Shockwave Medical, Inc. Zimmer Biomet Holdings, Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support